Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07292558 · ClinicalTrials.gov registry record · NA
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
A NA study of Diabetes Mellitus, Type 1 Diabetes, sponsored by University of British Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 306
- Enrollment target
- 1
- Study location
NCT07292558: Recruiting NA study of Diabetes Mellitus, Type 1 Diabetes, sponsored by University of British Columbia.
NCT07292558 is a NA study of Diabetes Mellitus, Type 1 Diabetes that is actively recruiting participants, run by University of British Columbia. The registered enrollment target is 306 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07292558, a NA study of Diabetes Mellitus, Type 1 Diabetes, is actively recruiting participants, sponsored by University of British Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care. Participants will be randomized to receive Usual Care or the AHEAD Program, which provides tailored support to emerging adults to build autonomy and competence to facilitate independent diabetes management. Researchers will compare changes in glycemia and participant-reported outcomes between groups.
Primary Outcome
HbA1c laboratory measurement.
Conditions Studied
Interventions
- BEHAVIORAL AHEAD Program
Study Locations (1)
Washington
- Seattle Children's - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT07292558 shows while recruiting
NCT07292558 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which AHEAD Program is the first listed.
NCT07292558 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07292558 about?
NCT07292558 is a clinical study titled "Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.". The goal of this study is to determine whether the Achieving Health in Emerging Adults with Diabetes (AHEAD) Program helps emerging adults with type 1 diabetes improve their blood glucose management during the transition from pediatric to adult care. Participants will be randomized to receive Usual...
What is the current status of trial NCT07292558?
This trial is currently recruiting. It is a NA study. The enrollment target is 306 participants. The study started on 2025-12-15. Estimated completion is 2028-12.
What conditions does trial NCT07292558 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1 Diabetes.
What interventions are being tested in trial NCT07292558?
The interventions under investigation include: AHEAD Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07292558?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07292558 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07292558's enrollment target sits among peer trials
306 324th of 2000 higher than 1,675 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI